Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Burkitt lymphoma as fourth neoplasia in a patient affected by Cowden Syndrome with a novel PTEN germline pathogenic variant

    Eugenio Galli, Francesco D’Alò, Annarosa Cuccaro, Eleonora Alma, Elena Maiolo, Fulvia Brugnoletti, Luigi Maria Larocca, Marcella Zollino, Andrea Paolo Bacigalupo, Stefan Hohaus
    e2020034
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.034
    1189
    PDF: 560
    HTML: 193
  • COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis

    Andrea Benetti, Irene Bertozzi, PhD, MD, Giulio Ceolotto, Irene Cortella, Daniela Regazzo, Giacomo Biagetti, Elisabetta Cosi, Maria Luigia Randi, MD, Prof
    e2024021
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.021
    760
    PDF: 1188
    HTML: 114
  • DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Sabina Chiaretti, Gina Zini, Renato Bassan
    e2014073
    2014-10-24
    https://doi.org/10.4084/mjhid.2014.073
    8813
    PDF: 5927
    HTML: 87436
    Fig.1b: 159
    Fig.1c: 164
    Fig.2a: 154
    Fig.2b: 154
    Fig.4: 167
    Fig.2c: 152
    Fig.3: 161
    Tab.1: 208
    Tab.2: 186
    Tab.3: 175
    Tab.4: 194
    Fig1a: 151
  • TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2023038
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.038
    1958
    PDF: 1572
    HTML: 344
  • Genetic modulators of diversity in biological expression of sickle cell anemia in patients from democratic republic of Congo

    MAMY NGOLE, MAMY NGOLE, GLOIRE MBAYABO, PAUL LUMBALA, VALERIE RACE, NONO MVUAMA, STEPHANIE DEMAN, ERIKA SOUCHE, PROSPER TSHILOBO LUKUSA, CHRIS VAN GEET, KOENRAAD DEVRIENDT, GERT MATTHIJS, AIME LUMAKA, ISABELLE CLEYNEN
    e2025001
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.001
    1592
    HTML: 213
    PDF: 1176
  • MICRORNA-181A-3P AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER FOR ACUTE MYELOID LEUKEMIA

    Xiaoling Ma
    e2020012
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.012
    1592
    PDF: 987
    HTML: 189
  • Association of the SOD2 polymorphism (Val6Ala) and SOD activity with vaso-occlusive crisis and acute splenic sequestration in children with sickle cell anemia

    Isabela Cristina Cordeiro Farias, Taciana Furtado Mendonça-Belmont, Andreia Soares Silva, Kleyton Palmeira do Ó, Felipe Borba Ferreira, Fernanda Silva Medeiros, Luydson Richardson Silva Vasconcelos, Moacyr Jesus Barreto de Melo Rego, Marcos Andre Cavalcanti Bezerra, Aderson Silva Araujo, Patricia Muniz Mendes Freire Moura, Ana Claudia Mendonça Anjos, Betânia Lucena Domingues Hatzlhofer, Maria do Socorro Mendonça Cavalcanti
    e2018012
    2018-02-21
    https://doi.org/10.4084/mjhid.2018.012
    2890
    PDF: 906
    HTML: 386
  • BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI

    Spinello Antinori, Laura Galimberti, Laura Milazzo, Mario Corbellino
    e2012013
    2012-03-09
    https://doi.org/10.4084/mjhid.2012.013
    5073
    PDF: 2472
    HTML: 30062
    Antinori Tables 1,2,3: 308
  • TREATMENT OF ADOLESCENT AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Josep-Maria Ribera, Jordi Ribera, Eulàlia Genescà
    e2014052
    2014-07-02
    https://doi.org/10.4084/mjhid.2014.052
    2518
    PDF: 1267
    HTML: 5884
  • GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

    Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau
    e2011019
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.019
    2504
    PDF: 769
    HTML: 5172
  • Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio

    Dr. Enrica A. Martino, Dr. G. Mele, Dr. F. Morabito, Dr. M. Gentile, Dr. E. Vigna
    e2025006
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.006
    2058
    PDF: 1510
    HTML: 247
  • RECENT ADVANCES IN THE 5Q- SYNDROME

    Andrea Pellagatti, Jacqueline Boultwood
    e2015037
    2015-05-20
    https://doi.org/10.4084/mjhid.2015.037
    2659
    PDF: 1732
    HTML: 3622
    Pellagatti Fig 1: 182
    Pellagatti Fig. 2: 181
  • ACQUIRED REFRACTORY IRON DEFICIENCY

    Margherita Migone De Amicis, Alessandro Rimondi, Luca Elli, Irene Motta
    e2021028
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.028
    2615
    PDF: 991
    HTML: 708
  • TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML

    Buket Altinok Gunes, Tulin OZKAN, Aynur Karadag Gurel, Semih Dalkilic, Nevin Belder, Zeynep Ozkeserli, Hilal Ozdag Sevgili, Meral Beksac, Nilgun Sayinalp, Abdullah Munci Yagci, Asuman Sunguroglu
    e2024058
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.058
    943
    PDF: 1067
    Suppl. Files: 548
    HTML: 71
  • COMMENT TO THE ARTICLE PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS. BY KOREN ET AL.

    Antonio Amato
    e2014021
    2014-03-10
    https://doi.org/10.4084/mjhid.2014.021
    1271
    PDF: 768
    HTML: 2373
  • CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2022069
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.069
    1822
    PDF: 813
    HTML: 1216
  • CAUSAL RELATIONSHIP BETWEEN HELICOBACTER PYLORI ANTIBODIES AND IMMUNE THROMBOCYTOPENIA: A MENDELIAN RANDOMIZATION STUDY

    Yuzhan Chen, Qitian Mu, Guifang Ouyang
    e2025.003
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.003
    1515
    PDF: 1199
    PDF: 891
    HTML: 251
  • THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS

    Gehan Lotfy Abdel Hakeem, hoda Abdel kereem Abdel Samei, Ashraf mohamed El Shereif, Ahlam mohamed ismail
    e2015023
    2015-02-17
    https://doi.org/10.4084/mjhid.2015.023
    2075
    PDF: 875
    HTML: 2985
    Untitled: 176
  • IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination

    Giuseppe Auteri, Simona Paglia, Camilla Mazzoni, Mattia Biondo, Marta Venturi, Andre Davide Romagnoli, Daniela Bartoletti, Michele Cavo, Nicola Vianelli, Francesca Palandri
    e2023029
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.029
    1231
    PDF: 743
    HTML: 291
  • THE PRICE OF MERCY: COMMENT TO THE PAPER "PREVENTION OF BETA-THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS” BY KOREN ET AL

    Eliezer Rachmilewitz
    e2014022
    2014-03-10
    https://doi.org/10.4084/mjhid.2014.022
    1435
    PDF: 928
    HTML: 2075
  • The IMPACT OF SUPEROXIDE DISMUTASE GENETIC POLYMORPHISM (SOD2 VAL16ALA) AND SUPEROXIDE DISMUTASE LEVEL ON DISEASE SEVERITY IN A COHORT OF EGYPTIAN SICKLE CELL DISEASE PATIENTS IN EGYPT SOD and SCD in Egypt

    Mervat Khorshied, Iman A, Shaheen, Yasmeen M.M Selim, Asmaa O. Elshahawy, Ilham Youssry
    e2022037
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.037
    1025
    PDF: 545
    HTML: 371
  • NOVEL RUNX1 VARIATION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

    Egzona Qipa, Muradiye Acar, Sureyya Bozkurt, Murat Buyukdogan, Hazal Berivan Sonmez, Muge Sayitoglu, Yucel Erbilgin, Zeynep Karakas, Veysel Sabri Hancer
    e2023036
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.036
    778
    PDF: 669
    HTML: 251
  • SUBTYPE DISTRIBUTION AND MUTATION SPECTRUM THALASSEMIA IN CHILDREN UNDER 10 YEARS IN NORTHERN VIETNAM

    Ngoc Dung Nguyen, Ha Thanh Nguyen, Thi Chi Nguyen, Thi Nguyet Anh Phi, Thi Thu Ha Nguyen, Thi Thu Huyen Le, Phuong Linh Hoang, Duc Binh Vu
    e2026002
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.002
    783
    PDF: 424
    Html: 121
  • NG2 MOLECULE EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA B CELLS: A FLOW-CYTOMETRIC MARKER FOR THE RAPID IDENTIFICATION OF KMT2A GENE REARRANGEMENTS

    Maria Laura Bisegna, Nadia Peragine, Loredana Elia, Mabel Matarazzo, Maria Laura Milani, Stefania Intoppa, Mariangela Di Trani, Francesco Malfona, Maurizio Martelli, Maria Stefania De Propris
    e2024018
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.018
    872
    PDF: 1239
    Suppl. Files: 816
    HTML: 144
  • EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

    Ali Bay, Enes Coskun, serdar oztuzcu, sercan ergun, fatih yilmaz, elif aktekin
    e2013066
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.066
    1321
    PDF: 654
    HTML: 1063
    Untitled: 162
    Untitled: 128
    Untitled: 112
    Untitled: 133
    Untitled: 139
  • TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.

    Aditi Singh, MD, Ishaq Asghar, MD, Laura Kohler, DO, Hosam Hakim, MD, Daniel Snower, MD, Daniel Lebovic, MD
    e2022018
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.018
    1568
    PDF: 697
    HTML: 446
  • RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM

    Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2023062
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.062
    1094
    PDF: 996
    HTML: 171
  • PROGNOSTIC VALUE OF PROTEASE ACTIVATED RECEPTOR-1 IN EGYPTIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Adel Abd Elhaleim Hagag
    e2014029
    2014-04-06
    https://doi.org/10.4084/mjhid.2014.029
    1286
    PDF: 743
    HTML: 2247
  • miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS

    Meiwan Cao, BaoLing Peng, WanFu Xu, PeiYu Chen, Huan Chen, LiPing Ye, Jing Xie, HongLi Wang, Lu Ren, LiYa Xiong, JingNan Zhu, XiangYe Xu, LanLan Geng, SiTang Gong
    e2023040
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.040
    654
    PDF: 782
    PDF Supp. Files: 68
    HTML: 169
  • PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues Plasma Cell Leukemia

    Giuseppe G.M. Leone, Ugo Testa
    e2025080
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.080
    815
    PDF: 281
    Html: 58
  • PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY

    Mohammad Ehsan Jaripour, Kourosh Hayatigolkhatmi, Vahid Iranmanesh, Farhad Khadivi Zand, Zahra Badiei, Hamid Farhangi, Ali Ghasemi, Abdollah Banihashem, Reza Jafarzadeh Esfehani, Ariane Sadr-Nabavi
    e2018042
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.042
    2304
    PDF: 887
    HTML: 355
    Supplementary table 1: 189
    Some of the mutation detection samples: 184
  • PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

    Michele Bibas
    e2024007
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.007
    3417
    PDF: 2323
    HTML: 1401
  • MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS

    Sanjay Pandey, Sweta Pandey, Rahasya Mani Mishra, Renu Saxena
    e2012001
    2012-01-15
    https://doi.org/10.4084/mjhid.2012.001
    1432
    PDF: 858
    HTML: 1396
    Table: 172
  • ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

    Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante
    e2022008
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.008
    1844
    PDF: 1040
    HTML: 552
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

    Michele Bibas, Shayna Sarosiek, Jorge J. Castillo
    e2024061
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.061
    2561
    PDF: 3085
    HTML: 309
  • LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY

    Ashraf Tawfik Soliman, Mohamed Yassin, Fawzia AlYafei, Lolwa Al-Naimi, Noora Almarri, Aml Sabt, Vincenzo De Sanctis
    e2014025
    2014-04-06
    https://doi.org/10.4084/mjhid.2014.025
    2112
    PDF: 2090
    HTML: 2399
  • DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia

    Buket Altinok Gunes, Yalda Hekmatshoar, Tulin Ozkan, Sureyya Bozkurt, O.Sena Aydos, Yahya Buyukasik, Elifcan Aladag, Asuman Sunguroglu
    e2023008
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.008
    1211
    PDF: 1127
    HTML: 419
  • THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA

    Yingying Li, Yang Li, Wenguo Cheng
    e2025073
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.073
    376
    PDF: 196
    HTML: 70
  • CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,

    Ugo Testa, Giuseppe Leone, Elvira Pelosi, Dr. Germana Castelli, Prof. Hohaus
    e2023066
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.066
    3525
    PDF: 1357
    HTML: 166
  • Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs

    Feiying Meng
    e2021041
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.041
    1055
    PDF: 452
    HTML: 210
  • EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

    Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca
    e2024042
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.042
    3952
    PDF: 1511
    HTML: 798
  • DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS

    HADI YASSINE
    e2022076
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.076
    1172
    PDF: 873
    HTML: 260
    Suppl. Figure: 170
    Suppl. Tables: 188
  • PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India

    Roshan Shaikh, Kanjaksha Ghosh, Ajit Gorakshakar
    e2025044
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.044
    1066
    PDF: 749
    HTML: 61
  • WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.

    Giorgio La Nasa, Adriana Vacca, Roberto Littera, Eugenia Piras, Sandro Orru, Marianna Greco, Carlo Carcassi, Giovanni Caocci
    e2016048
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.048
    3083
    PDF: 1096
    HTML: 1450
    Untitled: 158
    Untitled: 147
    Untitled: 147
  • BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN

    Maria Teresa Voso, Giulia Falconi, Dr. Fabiani
    e2023055
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.055
    1664
    PDF: 918
    HTML: 126
  • THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies

    Emine Atli, Rasime Kalkan, Cisem Mail, Damla Eker, Ufuk Demirci, Selma Demir, Sinem Yalcintepe, Hakki Onur Kirkizlar, Engin Atli, Hakan Gurkan, Ahmet Muzaffer Demir
    e2021013
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.013
    1406
    PDF: 497
    HTML: 235
  • Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era

    Serena Vita, Emanuela Giacobini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Spallanzani COVID-19 case Investigation Team
    e2024043
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.043
    1196
    PDF: 894
    HTML: 80
  • MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

    Ibrahim C. Haznedaroglu
    e2014009
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.009
    3798
    PDF: 1426
    HTML: 9169
    Untitled: 254
    Untitled: 158
    Untitled: 147
    Untitled: 143
    Untitled: 162
    Untitled: 315
  • KIR2DL2, KIR2DL5A and KIR2DL5B genes induce susceptibility to dengue virus infection while KIR3DL3 and KIR2DS5 confers protection

    Aziz Sidi Aristide TAPSOBA, Florencia Wendkuuni Djigma, Bagora BAYALA, Pegdwendé Abel SORGHO, Lassina TRAORE, Théodora Mahoukèdè ZOHONCON, Shoukrat Ohuwa Toyin BELLO, Prosper BADO, Bapio Valérie Elvira Jean Télesphore BAZIE, Fiffou YOUGBARE, Marius Ayaovi SETOR, Esther Mah Alima TRAORE, Dorcas OBIRI-YEBOAH, Albert Théophane YONLI, Jacques SIMPORE
    e2022075
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.075
    715
    PDF: 524
    PDF: 0
    HTML: 207
1 - 49 of 49 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy